Long-Term Follow-Up of Peritoneal Interposition Flap in Symptomatic Lymphocele Reduction following Robot-Assisted Radical Prostatectomy: Insights from the PIANOFORTE Trial
Christopher Goßler(University of Regensburg), Johannes Bründl(University of Regensburg), Christian Gilfrich(Barmherzige Brüder Klinikum St. Elisabeth in Straubing), Anton Ponholzer, Gjoko Stojanoski, Sebastian Lenart, Roman Mayr(Ospedale di Bolzano), Josef Riester(University of Regensburg), Isabel Anzinger, Matthias May(Barmherzige Brüder Klinikum St. Elisabeth in Straubing), Maximilian Burger(University of Regensburg), Steffen Weikert(St. Hedwig-Krankenhaus), Christina Dreissig
Cited by 1
Related Papers
The Epidemiology of Renal Cell Carcinoma
|European Urology|2011|1k
IMA901, a multipeptide cancer vaccine, plus sunitinib versus sunitinib alone, as first-line therapy for advanced or metastatic renal cell carcinoma (IMPRINT): a multicentre, open-label, randomised, controlled, phase 3 trial
|The Lancet Oncology|2016|218
Prediction of 90-day Mortality After Radical Cystectomy for Bladder Cancer in a Prospective European Multicenter Cohort
|European Urology|2014|206